The staff of the immunogenetics laboratory of the Novosibirsk Institute of molecular and cell biology (ECPS) SB RAS is the first in Russia has received antibodies that neutralize the coronavirus. Their discovery will form the basis for the creation of means of specific therapy and prevention COVID-19, TASS reported the responsible Secretary of working group under RAS to overcome new coronavirus infection Olga Dorokhova.
“In the Novosibirsk scientific center was the first in Russia received active antibody COVID-19. This was done using blood samples from survivors COVID-19 donors and the unique technology of sorting of single B-lymphocytes. These antibodies are able to block interaction of virus and cell receptor АСЕ2, respectively, to prevent its penetration into target cells,” said Dorokhov.
According to her, the further development of the study will allow scientists to create a means of specific therapy and prevention COVID-19. In addition, the obtained results will serve as material to study the characteristics of protective immunity during coronavirus infection and will be needed for the improvement of vaccines.